Malignant phyllodes tumours of the breast: the case for revising WHO's 'full house' diagnostic criteria
Tan, Puay Hoon Ellis, Ian O Allison, Kimberly H Badve, Sunil S Brogi, Edi Callagy, Grace Charafe-Jauffret, Emmanuelle Chen, Chih-Jung Chen, Yunn-Yi Collins, Laura C
Tan, Puay Hoon
Ellis, Ian O
Allison, Kimberly H
Badve, Sunil S
Brogi, Edi
Callagy, Grace
Charafe-Jauffret, Emmanuelle
Chen, Chih-Jung
Chen, Yunn-Yi
Collins, Laura C
Abstract
Phyllodes tumours (PTs) of the breast present diagnostic challenges due to their complex histological features and potential for malignant behaviour. The World Health Organisation (WHO) classification requires the presence of five adverse histological criteria to categorise PTs as malignant, aiming to avoid overdiagnosis and improve diagnostic consistency. However, emerging evidence suggests that these strict criteria may underdiagnose tumours with metastatic potential and histological features that would otherwise be considered malignant in soft tissue tumours, leading to significant implications for prognosis and treatment. Recent studies have highlighted cases where tumours classified as borderline PT by WHO criteria exhibited metastatic behaviour, emphasising the need to refine the diagnostic framework. Microscopic criteria used to classify PT also vary among reporting pathologists, resulting in suboptimal reproducibility. This review examines the histological parameters utilised in the classification of malignant PT, highlights existing evidence gaps and analyses international breast pathologist survey data to propose a pragmatic diagnostic approach. We recommend redefining malignant PTs to include cases meeting four of the five WHO criteria, supplemented by comprehensive sampling and clinical context. This approach balances the risk of underdiagnosis with the need for standardised, reproducible diagnostic practices. Future collaborative efforts should focus upon developing evidence-based, biologically relevant classification systems and leveraging technological advancements to enhance diagnostic precision. These efforts aim to refine classification, improve prognostic accuracy and optimise patient management strategies.
MIDER Authors
Date
2025-04-13
Type
Article
Subject
Pathology, Breast Neoplasms
Collections
Citation
Tan PH, Ellis IO, Allison KH, Badve SS, Brogi E, Callagy G, Charafe-Jauffret E, Chen CJ, Chen YY, Collins LC, Cserni G, Djerroudi L, Foschini MP, Fox SB, Gobbi H, Gudi M, Harada O, Jaffer S, Kulka J, Kuroda H, Lakhani SR, Li X, Moriya T, O'Toole S, Pinder SE, Provenzano E, Quinn C, Raymond W, Sahin AA, Schmitt F, Shaaban AM, Shet T, Siziopikou KP, Tang P, Tse GM, Varga Z, Vincent-Salomon A, Wen H, Yamaguchi R, Yang W, Schnitt SJ, Rakha EA. Malignant phyllodes tumours of the breast: the case for revising WHO's 'full house' diagnostic criteria. Histopathology. 2025 Aug;87(2):169-182. doi: 10.1111/his.15455. Epub 2025 Apr 13.
Journal / Source Title
Histopathology
DOI
10.1111/his.15455
PMID
40223225
Publisher
Blackwell Scientific Publications
Publisher’s URL
http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1365-2559